Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.
about
Third-generation beta-adrenoceptor antagonists in the treatment of hypertension and heart failureNitric oxide synthases in heart failureThe Principles of Ligand Specificity on beta-2-adrenergic receptorRationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension.Protective actions of nebivolol on chronic nitric oxide synthase inhibition-induced hypertension and chronic kidney disease in the rat: a comparison with angiotensin II receptor blockade.Nebivolol: impact on cardiac and endothelial function and clinical utility.Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockadeThe Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]iBeta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation.Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aortaProtective Effects of Vasodilatory Βeta-Blockers Carvedilol and Nebivolol against Glycerol Model of Rhabdomyolysis-Induced Acute Renal Failure in Rats.Effects of resveratrol and nebivolol on isolated vascular and cardiac tissues from young rats.Combined antihypertensive and cardioprotective effects of nebivolol and hydrochlorothiazide in spontaneous hypertensive rats.Functional characterization of CYP2C19 variants in nebivolol 4-hydroxlation in vitro.Protective Effects of the Third Generation Vasodilatory Βeta - Blocker Nebivolol against D-Galactosamine - Induced Hepatorenal Syndrome in Rats.Haemodynamic Influences of Bisoprolol in Hypertensive Middle-Aged Men: A Double-Blind, Randomized, Placebo-Controlled Cross-Over Study.Händigkeit - leben in einer chiralen Welt
P2860
Q26822825-AEE53B9E-B02E-4683-AE64-C959194350B5Q26830146-C057EB65-6BFD-400A-A25D-19904298E8F9Q28822521-DF88E9E6-A6F9-4885-8E8D-300BA4916B6AQ30491698-94CBA320-152C-4D3C-B582-1836214709C5Q35120875-2EA7C435-F149-49D5-9CE7-0BD1A882B5B0Q35788994-F05860F8-C92B-4A7A-ABE4-095E950F070FQ35846698-E4C84B35-47D2-404E-BB5F-3B1F3E042B53Q36141224-6C77A083-2E39-4A13-846B-401657608377Q36157478-EC08D4AA-D3D4-47A3-979C-6D3190EF76C5Q36652837-4C8258EF-9F3D-42A9-ADBE-95C1D06D754AQ37230717-1DF320FD-6B5B-4352-99BD-19358AD8A93AQ37297179-0030EB02-DF36-44D2-AF54-0815BE0101ECQ38256443-F034D4FE-A395-482A-8171-68BE1C69BD3AQ39690743-1328C979-9655-43A0-AE24-A0E635E5C3C1Q48369805-DC875865-9DBC-4487-8F55-C1423C71CEEAQ49362450-74B1D1D1-DA45-49B0-AB2F-DA537F1C350EQ53748994-842E144F-CDF6-4275-8737-D8E4892D8DCAQ56435336-770C8018-57AF-444A-8795-2C16D412E54B
P2860
Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Different pharmacological prop ...... nique beta-blocker, nebivolol.
@en
Different pharmacological prop ...... nique beta-blocker, nebivolol.
@nl
type
label
Different pharmacological prop ...... nique beta-blocker, nebivolol.
@en
Different pharmacological prop ...... nique beta-blocker, nebivolol.
@nl
prefLabel
Different pharmacological prop ...... nique beta-blocker, nebivolol.
@en
Different pharmacological prop ...... nique beta-blocker, nebivolol.
@nl
P2860
P1476
Different pharmacological prop ...... nique beta-blocker, nebivolol.
@en
P2860
P304
P356
10.1111/J.1527-3466.2008.00044.X
P577
2008-01-01T00:00:00Z